Metabolic dysfunction‐associated steatotic liver disease is associated with worse time in ranges in type 1 diabetes

Documenti analoghi

• Metabolic dysfunction‐associated steatotic liver disease and cancer risk: A cohort study
  di: Yu Peng, et al.
  Pubblicazione: (2025)
• Characterization of brain morphology associated with metabolic dysfunction‐associated steatotic liver disease in the UK Biobank
  di: Wenxiao Fan, et al.
  Pubblicazione: (2025)
• Glycaemic control metrics and metabolic dysfunction–associated steatotic liver disease in children and adolescents with type 1 diabetes
  di: Claudio Maffeis, et al.
  Pubblicazione: (2024)
• An interpretable machine learning model for predicting metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes
  di: Zhuolin Zhou, et al.
  Pubblicazione: (2025)
• Metabolic dysfunction‐associated steatotic liver disease and sex‐specific risk of fatal and non‐fatal cardiovascular events: A meta‐analysis
  di: Mohamad Jamalinia, et al.
  Pubblicazione: (2025)